Skip to content

Effects of Different Anesthesia Strategies on the Therapeutic Efficacy of Endovascular Intervention for Acute Ischemic Stroke

Anesthetic strategy and incidence of complicated effects of different anesthesia strategies on the therapeutic efficacy of endovascular intervention for acute ischemic strokes during the perioperative period of acute ischemic stroke intervention: A randomized, controlled clinical study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076880
Enrollment
Unknown
Registered
2023-10-23
Start date
2023-10-25
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Group R :Remazolam was the main anesthesia strategy
Group B:propofol was the main anesthesia strategy

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old, ASA grade II-IV, sign the relevant informed consent; 2. Diagnosis of acute ischemic stroke; 3. Anterior circulatory large vessel occlusion is found by CTA or MRA, and the condition is suitable for recanalization treatment, less than 24 hours from onset to initial treatment; 4. The modified Rankin Scale (mRS) score was <= 3 before stroke (mRS Range, 0= no symptoms to 6= death); 5. Baseline NIHSS score 0-30.

Exclusion criteria

Exclusion criteria: 1. Patients with intubated mechanical ventilation; 2. Data is missing; 3. Patients or their legal representatives refuse to participate.

Design outcomes

Primary

MeasureTime frame
Perioperative blood pressure changes;

Secondary

MeasureTime frame
NIH stroke scale;Operation time;time of anesthesia;Withdrawal - Extubation time;The time it takes for stroke patients to enter the hospital from the entrance to the successful vascular puncture, DPT;The time from the onset of stroke to receiving thrombolytic therapy, OPT;General information;High risk factor;Vascular occlusion site;modified thrombolysis in cerebral infarction;Postoperative complication;modified rankin scale ;

Countries

China

Contacts

Public ContactFu Lijuan

Deyang People's Hospital

17683086062@163.com+86 176 8308 6062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 17, 2026